Revak S D, Cochrane C G, Griffin J H
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.
The ability of human Hageman factor (coagulation factor XII) to bind to a glass surface and its susceptibility to limited proteolytic cleavage during the contact activation of plasma have been studied using normal human plasma and plasmas genetically deficient in factor XI, prekallikrein, or high molecular weight kininogen (HMWK). When diluted normal plasma containing (125)I-Hageman factor was exposed to a glass surface for varying times, the Hageman factor was found to bind to the surface, and within 5 min became maximally cleaved from its native 80,000 mol wt to yield fragments of 52,000 and 28,000 mol wt. Hageman factor in factor XI-deficient plasma behaved similarly. In prekallikrein-deficient plasma, the binding of Hageman factor to the glass surface occurred at the same rate as in normal plasma but the cleavage was significantly slower, and did not reach maximum until 60 min of incubation. Cleavage of Hageman factor in HMWK-deficient plasma occurred at an even slower rate, with greater than 110 min of incubation required for maximal cleavage, although the rate of binding to the glass was again the same as in normal plasma. Normal rates of cleavage of Hageman factor were observed for the deficient plasmas after reconstitution with purified human prekallikrein or HMWK, respectively. These observations suggest that normal contact activation in plasma is associated with proteolytic activation of surfacebound Hageman factor. The cleavage of the surface-bound Hageman factor molecule responsible for the formation of the 52,000-and 28,000-mol wt fragments occurred at two closely situated sites, one of which was within a disulfide loop. Cleavage at the site external to the disulfide bond resulted in the release from the surface of the 28,000-mol wt fragment. Cleavage at the site within the disulfide loop resulted in the formation of a 28,000-mol wt fragment which remained surface bound, presumably by virtue of the disulfide linkage to the larger fragment.
利用正常人血浆以及缺乏因子XI、前激肽释放酶或高分子量激肽原(HMWK)的遗传性血浆,研究了人Hageman因子(凝血因子XII)与玻璃表面结合的能力及其在血浆接触激活过程中对有限蛋白水解切割的敏感性。当含有(125)I-Hageman因子的稀释正常人血浆与玻璃表面接触不同时间后,发现Hageman因子与表面结合,并在5分钟内从其天然的80,000分子量最大程度地切割成52,000和28,000分子量的片段。因子XI缺乏血浆中的Hageman因子表现类似。在前激肽释放酶缺乏的血浆中,Hageman因子与玻璃表面的结合速率与正常人血浆相同,但切割明显较慢,直到孵育60分钟才达到最大值。HMWK缺乏血浆中Hageman因子的切割速率更慢,最大切割需要超过110分钟的孵育,尽管与玻璃的结合速率再次与正常人血浆相同。分别用纯化的人前激肽释放酶或HMWK重构缺乏血浆后,观察到Hageman因子的正常切割速率。这些观察结果表明,血浆中的正常接触激活与表面结合的Hageman因子的蛋白水解激活有关。负责形成52,000和28,000分子量片段的表面结合Hageman因子分子的切割发生在两个紧密相邻的位点,其中一个位于二硫键环内。二硫键外部位点的切割导致28,000分子量片段从表面释放。二硫键环内位点的切割导致形成一个28,000分子量的片段,该片段可能通过与较大片段的二硫键连接而保持与表面结合。